SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 9.38 |
| Enterprise Value ($M) | 13.23 |
| Book Value ($M) | 1.46 |
| Book Value / Share | 0.07 |
| Price / Book | 6.42 |
| NCAV ($M) | -0.85 |
| NCAV / Share | -0.04 |
| Price / NCAV | -11.05 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.79 |
| Return on Assets (ROA) | -1.84 |
| Return on Equity (ROE) | -6.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.16 |
| Current Ratio | 0.16 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.15 |
| Assets | 2.46 |
| Liabilities | 1.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,971 | 62,833 | 6.32 | |
| 41,305 | 83,142 | 49.68 | |
| 4,910 | 30,142 | 16.29 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IXHL – Incannex Healthcare Inc. | JANX – Janux Therapeutics, Inc. |
| KALV – KalVista Pharmaceuticals, Inc. | KOD – Kodiak Sciences Inc. |
| KROS – Keros Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io